gastric cancer articles & resources on Made-in-China.com

Update on Her2/Neu (4b5) Rabbit Monoclonal Primary Antibody Assay Is Provided by Ventana

Dec 17, 2013

Ventana Medical Systems (Ventana), a member of the Roche Group, has announced that its Ventana HER2/neu (4B5) rabbit monoclonal primary antibody assay is now a companion diagnostic for detecting HER2 protein expression for patients who, in ...

Tags: Ventana, Medical Systems

Eli Lilly and Company Has Received Priority Review Status From The FDA

Oct 25, 2013

Eli Lilly and Company has received priority review status from the US Food and Drug Administration (FDA) for its ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial ...

Tags: Cancer Drug, FDA Priority

Ambrx and China-Based Zhejiang Medicine Collaborated to Develop and Commercialize ARX788

Jun 21, 2013

US-based Ambrx and China-based Zhejiang Medicine have collaborated to develop and commercialize ARX788, an antibody drug conjugate (ADC) targeting Her2-positive breast cancer. As per the deal, both the companies will advance the product ...

Tags: Ambrx, Medicine

Finnish Drug Maker Biohit Oyj Will Reportedly Launch Patent Drug Acetuim

May 14, 2013

Finnish drug maker Biohit Oyj will reportedly launch patent drug Acetuim that could control blastomogen acetaldehyde, which is oriented to the Chinese market, revealed the CEO of the company Semi Korpela. Biohit Oyj is currently ...

Tags: Stomach Medicine, Medicine

Infection Is The Cause of Most Stomach and Duodenal Ulcers But Can Be Simply Cured

Dec 20, 2012

Infection with Helicobacter pylori is the cause of most stomach and duodenal ulcers but can be simply cured by a course of antibiotics. Easy detection is therefore clinically important. Traditional non-invasive tests for diagnosis of H. ...

Tags: Helicobacter pylori, antibiotics, Antigen test

The Clinical Trials for The Her2-Targeted PET Imaging Agent Is Scheduled to Begin Later

Dec 14, 2012

Affibody has entered into a collaboration agreement with GE Healthcare to develop a Her2-targeted PET imaging agent for detecting breast and gastric cancer. The clinical trials for the Her2-targeted PET imaging agent is scheduled to ...

Tags: company cooperation, clinical research, breast cancer, gastric cancer

gastric cancer